ORIGINAL RESEARCH article

Front. Mater., 30 October 2026

Sec. Colloidal Materials and Interfaces

Volume 13 - 2026 | https://doi.org/10.3389/fmats.2026.1911252

5-fluorouracil-loaded Mn-doped ZnO nanocomposite: synthesis, characterization, and antibacterial activity

  • RZ

    Rida Zafar 1

  • IJ

    Irum Jamil 1

  • SB

    Samreen Bibi 1

  • FN

    Faisal Nawaz 1*

  • SW

    Syed Waqas Hassan 2

  • ME

    Md Enamul Hoque 3*

  • 1. Department of Chemistry, University of Wah, Rawalpindi, Punjab, Pakistan

  • 2. Department of Biosciences, University of Wah, Rawalpindi, Punjab, Pakistan

  • 3. Department of Mechanical Engineering, Faculty of Engineering, University of Tabuk, Tabuk, Saudi Arabia

Abstract

Antimicrobial resistance has intensified the search for alternative strategies to combat drug-resistant bacterial pathogens. Although 5-fluorouracil (5-FU) exhibits intrinsic antibacterial activity, its clinical antimicrobial application may be limited by dose-dependent toxicity. This study aimed to develop a 5-FU-loaded Mn-doped ZnO nanocomposite and evaluate its structural characteristics and antibacterial activity against the Gram-positive bacterium Staphylococcus aureus and the Gram-negative bacterium Escherichia coli. The nanocomposite was synthesized by co-precipitation and characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDX), UV–visible spectroscopy, and Fourier-transform infrared (FTIR) spectroscopy. Complementary spectroscopic and structural analyses evaluated the optical band-gap characteristics and successful incorporation of Zn, Mn, and 5-FU. The 5-FU-loaded Mn-doped ZnO nanocomposite demonstrated notable antibacterial activity against both bacterial strains. At concentrations of 15 and 10 μL, the nanocomposite produced inhibition zones of 16.8 and 13.8 mm against S. aureus, respectively, and 14.8 and 12.5 mm against E. coli. The greater inhibition against S. aureus indicates comparatively higher susceptibility of the Gram-positive strain to the nanocomposite. Overall, the findings demonstrate that 5-FU-loaded Mn-doped ZnO nanocomposites exhibit promising broad-spectrum antibacterial activity and may offer a nanomaterial-based strategy to enhance the antimicrobial utility of 5-FU while potentially reducing the required drug dose.

Graphical Abstract

Highlights

  • Mn-doped ZnO nanocomposites were synthesized by the co-precipitation method.

  • 5-FU was loaded on Mn-doped ZnO nanocomposite.

  • 5-FU-loaded Mn-doped ZnO NCs were characterized using the techniques UV, FTIR, SEM, XRD, EDS, and elemental Mapping.

  • The antibacterial activity of unloaded Mn–Zn–O material and the 5-FU-associated formulation was evaluated against E. coli and S. aureus using the agar-well diffusion method.

1 Introduction

The discovery of antibiotics was one of the greatest advances in 20th-century medicine, revolutionizing the treatment of bacterial infections. Ancient civilizations used natural extracts for therapeutic purposes (Muteeb et al., 2023), while subsequent advances in antibiotic discovery and synthesis transformed the management of infectious diseases. Antibiotics act through different mechanisms, including inhibition of bacterial cell-wall synthesis and interference with protein and DNA synthesis. However, their widespread and inappropriate use has contributed to the emergence of antimicrobial resistance and multidrug-resistant bacterial strains (Verma et al., 2022; Bibi et al., 2025; Zhang et al., 2025). In addition, bacterial biofilms and associated infections pose significant global health challenges due to their increased resistance to conventional antimicrobial agents (Verma et al., 2022; Bibi et al., 2025; Zhang et al., 2025). These growing concerns have created an urgent need for alternative and effective strategies to combat bacterial infections and resistant pathogens. 5-Fluorouracil (5-FU) is an antimetabolite in which a fluorine atom replaces hydrogen at the C5 position of the uracil ring. This structural substitution enables 5-FU to interfere with nucleic acid synthesis, primarily by inhibiting thymidylate synthase and thereby disrupting the conversion of deoxyuridine monophosphate to deoxythymidine monophosphate, which is essential for DNA synthesis. Since its introduction in 1960, 5-FU has been widely used to treat various cancers, including breast, gastrointestinal, head and neck, and skin cancers. Following administration, 5-FU is metabolized into active metabolites, including fluorodeoxyuridine monophosphate (FdUMP) and fluorouridine triphosphate (FUTP), which interfere with DNA replication and RNA function, respectively (Alzahrani et al., 2023; Mafi et al., 2023).

5-Fluorouracil (5-FU) is an FDA-approved anticancer agent that effectively inhibits thymidylate synthase, an enzyme crucial for DNA synthesis. In addition to its anticancer activity, 5-FU has potential as an antibacterial agent. It can induce thymineless death in Escherichia coli by inhibiting thymidylate synthase, a key enzyme involved in DNA synthesis. Moreover, 5-FU has been reported to inhibit biofilm formation in various pathogens (Lin and Huang, 2024; Jamil et al., 2024a; Haque et al., 2025). Once inside the body, 5-FU is converted into its active metabolite, fluorodeoxyuridine monophosphate (FdUMP) (Suetsugu et al., 2021). Biochemical assays have also demonstrated that 5-FU can induce significant damage to bacterial DNA and promote the production of reactive oxygen species (ROS) (Zhang et al., 2024). However, 5-FU has a short half-life, and its therapeutic use is limited by reduced bioavailability, poor absorption, and rapid elimination (Xia et al., 2024). It also has toxic effects on cells by generating free radicals (Savcı et al., 2022).

To overcome the limitations and side effects associated with 5-FU, there is a need for improved drug delivery systems that can control drug release, maintain the appropriate dosage, and enable targeted delivery. Various carriers have been developed to improve 5-FU delivery, including biopolymers such as cellulose and chitosan, natural zeolites, and other materials such as kaolinite (Anjum et al., 2024; Sayed et al., 2022). Nanotechnology-based drug delivery systems have also attracted considerable attention for their ability to enable targeted, controlled delivery to specific cells or tissues, potentially improving therapeutic efficacy while reducing systemic side effects. Due to their large surface-area-to-volume ratio, they can move through the bloodstream (Haleem et al., 2023; Jamil et al., 2024b). Nanotechnology has been increasingly applied in diagnostic sciences to rapidly identify various diseases (Malik et al., 2023). Metallic nanoparticles offer several advantages, including high drug-loading capacity, structural stability, ease of surface modification, and enhanced therapeutic activity arising from their catalytic and oxidative properties (Abed et al., 2025). Nanoparticles are generally classified as zero-dimensional nanomaterials when all three spatial dimensions are confined to the nanoscale range (Joseph et al., 2023).

Nanoparticles may reduce the likelihood of bacterial resistance because they can exert antimicrobial effects through multiple mechanisms, whereas conventional antibiotics often act through specific molecular targets and defined modes of action, potentially increasing the likelihood of resistance development in pathogens (Ingle et al., 2022). Antimicrobial materials can be broadly classified into three main categories: inorganic, organic, and natural materials. Inorganic antimicrobial agents are generally more expensive but offer several advantages, including long-term stability and durability. Organic antimicrobial agents are typically low-cost and provide rapid antimicrobial action; however, they may have limitations, including poor thermal stability and a greater potential to induce antimicrobial resistance. Natural antimicrobial agents generally exhibit excellent biocompatibility but may have limited antimicrobial efficacy and stability (Zhao et al., 2026).

Gram-positive bacteria possess a negatively charged cell surface primarily due to the presence of teichoic acids in their cell wall, whereas Gram-negative bacteria exhibit a negative surface charge largely associated with lipopolysaccharides in their outer membrane (Szentirmai et al., 2021). Metallic nanoparticles can interact with negatively charged bacterial cell walls through electrostatic and coordination interactions, facilitating their attachment to the cell surface. In addition, positively charged metallic nanoparticles can disrupt the bacterial cell wall and increase membrane permeability. Furthermore, extracellular metal ions released from metallic nanoparticles may enter bacterial cells and interfere with essential cellular functions, contributing to their antibacterial activity (Gautam et al., 2023).

Because of their high loading capacity, enhanced bioavailability, reduced toxicity, and improved drug stability, nanoparticles (NPs) offer several advantages for delivering therapeutic agents, including site-directed delivery and controlled release. They can also enhance antibacterial activity (Ibraheem et al., 2022; Jamil et al., 2026). Because of their small size, metal NPs can more readily interact with and cross biological membranes, facilitating cellular uptake compared with larger macromolecules (Chandrakala et al., 2022; Nawaz et al., 2023). Zinc is an essential trace element in the human body and plays important roles in metabolism, cell growth, reproduction, and immune system development. It also protects cells against oxidative damage because Zn does not readily undergo redox cycling under physiological conditions (Kiouri et al., 2023). Zn nanoparticles (NPs) differ from conventional bulk Zn materials in their mechanical, optical, electrical, thermal, chemical, and magnetic properties and typically range from 1 to 100 nm in size (Zhou et al., 2023; Singh et al., 2023). ZnO has numerous applications in drug delivery because of its unique physicochemical properties. ZnO NPs also exhibit antibacterial activity against a broad range of pathogenic microorganisms (Li et al., 2023). Among inorganic nanoparticles, ZnO NPs are promising drug carriers owing to their distinctive properties, relatively simple, cost-effective preparation, and potential for large-scale production (Yue et al., 2026).

ZnO single crystals have been used to investigate orientation-dependent mechanical behavior, including load–indentation depth responses, atomic displacement, shear strain, and dislocation formation (Zhu et al., 2025). The antimicrobial activity of ZnO nanoparticles depends on several physicochemical properties, including particle shape, surface area, and size. For example, quasi-spherical ZnO nanoparticles may release more Zn2+ ions, thereby enhancing antimicrobial activity (Junaid et al., 2026; Pino et al., 2023). Manganese, a transition metal, and its nanocomposites have attracted increasing attention in biomedical and drug delivery applications because of their distinctive physicochemical properties, magnetic behavior, biostability, and environmental compatibility (Mohammad et al., 2023). Because of its multiple oxidation states (Mn2+, Mn3+, and Mn4+), manganese oxide has also attracted considerable interest for various biomedical applications (Manavalan et al., 2024). Owing to its relatively high solubility, large magnetic moment, abundance of electronic states, and ability to form single-phase crystal structures with different oxidation states, Mn is considered a promising dopant among transition metals. In addition, the comparable ionic radii of Mn2+ (0.80 Å) and Zn2+ (0.74 Å) facilitate the incorporation of Mn into the ZnO lattice (PS and VT, 2024). Mn-doped ZnO nanoparticles have demonstrated significant antibacterial activity against various bacterial species, including Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa, and Escherichia coli (Pally et al., 2024). Similarly, 5-FU exhibits antibacterial activity against both Gram-positive and Gram-negative bacteria, while Mn-doped ZnO nanocomposites possess strong antibacterial properties. Therefore, this study aimed to load 5-FU onto the surface of Mn-doped ZnO nanocomposites to improve drug delivery and potentially mitigate the adverse effects associated with 5-FU.

2 Experimental

2.1 Chemicals

The starting materials used in this study were zinc acetate dihydrate, manganese acetate tetrahydrate, sodium hydroxide, and 5-fluorouracil (5-FU). Distilled water was used as the solvent throughout the experiments. Sodium hydroxide or hydrochloric acid solutions were used to adjust the pH as required. All reagents were of 99.5% purity. Following thorough acid cleaning, all apparatus was carefully rinsed with tap water, then distilled water, before use. Deionized water was used as the solvent throughout this experiment.

2.2 Synthesis of Mn-doped ZnO nanocomposite

Manganese acetate tetrahydrate and zinc acetate dihydrate were weighed according to the required stoichiometric ratio to synthesize Mn-doped ZnO nanoparticles. Briefly, 1.65 g of zinc acetate was dissolved in 15 mL of deionized water to prepare a 0.5 M zinc acetate solution. Similarly, 0.2 g of manganese acetate was dissolved in 15 mL of deionized water to prepare a 0.05 M manganese acetate solution. The molar ratio of Mn was maintained at 1:10. The two precursor solutions were then combined in a conical flask under continuous stirring and mixed thoroughly. A 0.5 M NaOH solution was prepared separately in a similar manner. The NaOH solution was transferred into a burette and added dropwise to the mixed zinc acetate and manganese acetate solution, with continuous stirring, until the pH reached 9.

The resultant solution was stirred continuously for approximately 2 h, after which precipitates formed. The precipitates were washed several times with ethanol and double-distilled water to remove residual impurities. The washed precipitates were then dried at room temperature for 24 h. Finally, the resulting powder was annealed in a furnace at 300 °C for 2 h, as shown in Figure 1. Mn-doped ZnO nanoparticles were synthesized using 0.5 M Zn precursor and 0.05 M Mn precursor, corresponding to a nominal Mn content of 9.1 at% of the total metal cations, based on the precursor ratio. Quantitative EDS analysis revealed an experimental Mn content of approximately 8.3 at% of the total metal cations, calculated as Mn/(Mn + Zn), corresponding to an Mn/Zn atomic ratio of approximately 0.091.

FIGURE 1

2.3 Loading of 5-fluorouracil on Mn-doped ZnO nanocomposite

A total of 5 mg of 5-fluorouracil (5-FU) was dissolved in 25 mL of distilled water and mixed with 25 mg of the synthesized Mn-doped ZnO nanocomposite dispersed in 50 mL of water. The mixture was continuously stirred for 24 h at 25 °C. The mixture pH was maintained at six throughout the loading process. Following incubation, the 5-FU-loaded nanoparticles were separated by centrifugation at 10,000 rpm for 10 min at 25 °C, as shown in Figure 2. We determined the amount of 5-FU remaining in the supernatant using UV–Vis spectroscopy to estimate drug-loading efficiency, as illustrated in Figure 3. The concentration of 5-FU in the metal nanocomposite was determined from its characteristic absorbance peak at 248 nm. The drug loading content (DLC%) and drug encapsulation efficiency (DEE%) were calculated using Equations 1 and 2, respectively.

FIGURE 2

FIGURE 3

2.4 Drug release

The 5-FU-loaded nanocomposite was added to a conical flask containing 50 mL of phosphate-buffered saline (PBS) and allowed to release for 120 h. At predetermined intervals of 0, 1, 2, 4, 6, 8, 10, 12, 14, 24, 36, 48, 72, and 120 h, 0.1 mL of the release medium was withdrawn using a pipette and diluted to 10 mL with PBS. The diluted samples were allowed to stand for 5 min before measuring absorbance by UV–Vis spectroscopy. We added an equal volume of fresh PBS to the release medium after each sampling to maintain a constant volume. The concentration of released 5-FU was calculated using the linear regression equation obtained from the calibration curve. As shown in Figure 4, the cumulative release of 5-FU reached approximately 40% at 12 h and 71% at 120 h. The cumulative release profile exhibited an initial burst, with approximately 40% of 5-FU released within the first 12 h, followed by a slower, sustained release that reached approximately 70% at 120 h. The initial burst may be attributed to 5-FU molecules loosely attached to or located near the nanocomposite surface, whereas the subsequent sustained release may reflect the gradual diffusion of more strongly retained drug molecules from the nanocomposite, as shown in Figure 4.

FIGURE 4

3 Results and discussion

3.1 UV spectroscopy

The synthesis of the nanomaterial was confirmed by recording optical spectra of Mn-doped ZnO Nanocomposites. UV–Visible absorption spectra were recorded at room temperature using a UV spectrophotometer over the wavelength range 200–400 nm. For optimization, spectra were recorded every 30 min for all aliquots over time. Mn-doped ZnO nanocomposite shows maximum absorbance at 281 nm while 5-FU loaded on the Mn-doped ZnO nanocomposite has a maximum peak absorbance at 249nm, as shown in Figure 5. In this spectrum, a red shift was observed.

FIGURE 5

When an electron is excited from the valence band to the conduction band, the total absorption is measured to determine the optical band gap (E.g.,) value. Tauc’s law is used to estimate the link between the incident photon energy (hυ) and the absorption coefficient (α) in the situation of a semiconductor’s high absorption area. The absorption coefficient was calculated using the following Equation 3:

To excite an electron from its lower energy band to its higher energy band, energy is required, as indicated by the optical energy band gap. Band gap energy for Mn-doped ZnO nanocomposite is 3.13eV and for 5-FU loaded on Mn-doped ZnO nanocomposite is 2.92eV with direct transitions as shown in Figure 5. Tauc’s equation is given by Equation 4:

The optical band-gap energies of the synthesized Mn-doped ZnO and 5-FU-loaded Mn-doped ZnO nanocomposites were determined using Tauc plot analysis, as shown in Figure 6. The extrapolation of the linear portion of the plots of the energy axis yielded band-gap energies of approximately 3.13 eV for Mn-doped ZnO and 2.92 eV for the 5-FU-loaded Mn-doped ZnO nanocomposite. Thus, the incorporation of 5-FU resulted in a reduction of approximately 0.21 eV in the apparent optical band gap.

FIGURE 6

The decrease in band-gap energy after 5-FU loading indicates a change in the optical and electronic properties of the Mn-doped ZnO nanocomposite. The interaction of 5-FU molecules with the nanocomposite surface may introduce additional electronic states or modify the surface electronic environment, thereby facilitating electronic transitions at lower photon energies. This reduction in the apparent band gap may also indicate enhanced light absorption in the visible or near-visible region. Such electronic-structure modification can influence charge-carrier generation and separation and may contribute to the functional performance of the 5-FU-loaded nanocomposite. Overall, the Tauc analysis demonstrates that 5-FU loading substantially modifies the optical properties of Mn-doped ZnO, with the band gap decreasing from 3.13 to 2.92 eV.

3.2 FTIR spectroscopy

FTIR spectroscopy was performed to identify the functional groups and chemical bonds present in the 5-fluorouracil (5-FU)-loaded Mn-doped ZnO nanocomposite. The FTIR spectra of the Mn-doped ZnO and 5-FU-loaded Mn-doped ZnO nanocomposites exhibited characteristic absorption bands at approximately 3500, 1740, 1595.8, 1380, 863, 700, 600, and 510 cm-1. The bands at 1250 and 1230 cm-1 were assigned to C–N and C–F groups, respectively, while the band at 3335 cm-1 was attributed to–OH stretching. The absorption band at 1647 cm-1 corresponded to the C=O group, whereas the band at 825 cm-1 was associated with C–H vibrations, as presented in Table 1. The spectral region between 450 and 620 cm-1 was attributed to Zn–O–Zn and Mn–O vibrations, while the peak around 450 cm-1 may be associated with the antisymmetric stretching mode of Zn–O–Zn bonds. In addition, the peak observed at 1120 cm-1 suggests the presence of Zn–OH-related vibrations. These characteristic absorption bands confirm the presence of the corresponding functional groups and metal–oxygen bonds in the nanocomposite, as shown in Figure 7.

TABLE 1

Sr noWavenumberFunctional groupAssignmentReferences
1450cm-1O-Zn-OStretching vibration(Bonifácio et al., 2017)
2620cm-1Mn-OStretching(Bonifácio et al., 2017)
33409 cm-1N-Hstretching(Jubeen et al., 2020)
41647cm-1C=Ostretching(Jubeen et al., 2020)
53335cm-1-OHStretching vibration(Arafat et al., 2020)
61230 cm-1C-FStretching vibration(Arafat et al., 2020)
71250 cm-1C-NStretching vibration(Arafat et al., 2020)
8825 cm-1C-Hdeformation(Arafat et al., 2020)
ta1270 cm-1C-Ostretching(Arafat et al., 2020)

Wavenumber, functional group and peak assignment.

FIGURE 7

3.3 XRD spectra

X-ray diffraction (XRD) analysis was performed to determine the crystalline structure and phase composition of the synthesized nanoparticles. The XRD patterns of the Mn-doped ZnO nanocomposite and 5-FU-loaded Mn-doped ZnO nanocomposite were recorded over a 2θ range of 35°–80°. The sharp and well-defined diffraction peaks indicate the crystalline nature of the synthesized Mn-doped ZnO nanocomposite. The observed diffraction peaks of the Mn-doped ZnO nanocomposite were in good agreement with the standard reference pattern JCPDS No. 96-901-2843, confirming the formation of the ZnO crystalline phase. The Mn-doped ZnO nanocomposite exhibited a tetragonal crystal system with the compound identified as hetaerolite and a space group of I41/amd (No. 141). The diffraction peaks of the 5-FU-loaded Mn-doped ZnO nanocomposite were in good agreement with JCPDS No. 96-410-5959, corresponding to an orthorhombic crystal system with a Pmmm space group. These results indicate that incorporating 5-FU was associated with a change in the nanocomposite’s crystalline structure. The XRD diffractograms of the synthesized Mn-doped ZnO nanocomposite and 5-FU-loaded Mn-doped ZnO nanocomposite with different compositional ratios exhibited distinct diffraction peaks at 2θ values of approximately 31°, 35°, 36.1°, 39°, 52°, 62°, and 67°, which were indexed to the (111), (110), (101), (120), (220), (200), (221), and (222) planes, respectively, as shown in Figure 8.

FIGURE 8

3.4 SEM images

The surface morphology and elemental composition of the synthesized Mn-doped ZnO and 5-FU-loaded Mn-doped ZnO nanocomposites were analyzed using scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDX). The Mn-doped ZnO nanocomposite exhibited predominantly spherical or granular morphology, as shown in Figures 9a,b. The SEM images also revealed morphological changes associated with the doping concentration. The average particle sizes were approximately 17 and 20 nm, as determined from the corresponding particle-size distribution analysis. The EDX spectrum of the Mn-doped ZnO nanocomposite showed characteristic peaks corresponding to Zn, O, and Mn, confirming the presence of the expected elements. No additional significant elemental peaks were detected, suggesting a relatively high degree of compositional purity.

FIGURE 9

The SEM images of the 5-FU-loaded Mn-doped ZnO nanocomposite revealed a flaky or plate-like morphology, which may be associated with the deposition or loading of 5-FU onto the Mn-doped ZnO surface. The particles appeared closely packed, with no obvious gaps between them, as shown in Figure 10.

FIGURE 10

3.5 EDX of nanocomposites

Energy-dispersive X-ray spectroscopy (EDX) is an analytical technique used to determine a sample’s elemental composition by analyzing the characteristic X-rays emitted when an electron beam interacts with the sample in an SEM. The EDX spectrum of the Mn-doped ZnO nanocomposite showed distinct peaks corresponding to Zn, Mn, C, and O, as shown in Figure 11.

FIGURE 11

The Zn peak exhibited the highest intensity, consistent with Zn being the major elemental component of the nanocomposite. The EDX spectrum of the 5-FU-loaded Mn-doped ZnO nanocomposite showed characteristic peaks corresponding to Mn, Zn, O, C, F, and N, as shown in Figure 12. The appearance of F and N peaks in the loaded nanocomposite is consistent with the presence of 5-FU, while the Zn peak remained dominant because of its relatively high concentration.

FIGURE 12

Elemental mapping combines SEM and EDX analysis to visualize the spatial distribution of elements within the nanoparticle sample. It provides information on the distribution and relative abundance of different elements throughout the nanocomposite. For the Mn-doped ZnO nanocomposite, the elemental mapping showed carbon in blue, oxygen in grey, Mn in yellow, and Zn in purple, as shown in Figures 13a–d.

FIGURE 13

The elemental mapping of the 5-FU-loaded Mn-doped ZnO nanocomposite also demonstrated the distribution of the constituent elements. In this sample, carbon, nitrogen, oxygen, fluorine, Mn, and Zn were represented by blue, green, grey, pink, yellow, and purple, respectively, as shown in Figures 14a–d.

FIGURE 14

3.6 Antibacterial activity of Mn-Doped ZnO and 5-FU-loaded Mn-Doped ZnO NCs

3.6.1 Well diffusion method

The agar well diffusion assay generally consists of several steps and typically requires 18–48 h, depending on the test microorganism. The test microorganisms were first cultured by inoculating them onto an appropriate growth medium and incubating them under optimal conditions. Once the cultures reached the required growth phase, we prepared a homogeneous bacterial lawn by evenly spreading the microbial suspension over the surface of an agar plate using a sterile cotton swab. Sterile wells of a suitable size were then prepared in the agar using a sterile cork borer or pipette tip, and the test nanocomposite samples were carefully added to the wells, as shown in Figure 15. The plates were subsequently incubated for a predetermined period at the appropriate temperature to allow the samples to diffuse into the surrounding agar medium. Following incubation, the plates were examined for the formation of inhibition zones, and their diameters were measured to evaluate the antibacterial activity of the tested compounds. Appropriate control plates containing only the solvent, culture filtrate, or buffer were included to account for any potential effects of the vehicle on microbial growth. All antibacterial experiments were performed in triplicate, and the results were expressed as mean ± standard deviation.

FIGURE 15

3.6.2 Proposed mechanism of antimicrobial activity of 5-FU + Mn-doped ZnO

Metal oxide nanocomposites (NCs) play an important role as antibacterial agents, primarily because they can disrupt essential cellular processes. Zinc oxide (ZnO), a wide-bandgap semiconductor with a band gap of approximately 3.3 eV, can exhibit photocatalytic activity under suitable irradiation. Upon irradiation with sufficient energy, electrons are excited from the valence band (VB) to the conduction band (CB), generating electron–hole pairs. The photogenerated holes in the valence band possess strong oxidizing potential and can react with surrounding water molecules or hydroxyl ions to generate reactive oxygen species (ROS) (Bonifácio et al., 2017). These ROS can cause oxidative damage to bacterial cell membranes and other essential cellular components, thereby contributing to bactericidal activity, as shown in Figure 16. In this study, Mn was incorporated into ZnO, followed by loading of 5-FU onto the Mn-doped ZnO nanocomposite, resulting in enhanced antibacterial activity compared with the unloaded Mn-doped ZnO nanocomposite and the positive control, amoxicillin. Mn doping can modify ZnO’s electronic and optical properties, potentially influencing charge separation and ROS generation. Furthermore, 5-FU loading may provide an additional antibacterial mechanism through its interaction with bacterial nucleic acid synthesis. The combined effects of Mn-doped ZnO and 5-FU may therefore contribute to the enhanced antibacterial activity observed for the 5-FU-loaded Mn-doped ZnO nanocomposite.

FIGURE 16

The Gram-positive pathogen S. aureus and Gram-negative pathogen E. coli, obtained from the Department of Biosciences, University of Wah, were tested against different quantities of the synthesized Mn-doped ZnO and 5-FU-loaded Mn-doped ZnO nanocomposites. We used a laminar flow cabinet throughout the experimental procedure to maintain aseptic conditions. Fresh bacterial cultures were prepared by inoculating 200 µL of the respective bacterial culture into Petri dishes containing 15 mL of the appropriate growth medium. The bacterial inoculum was adjusted to a 0.5 McFarland standard and evenly spread onto Mueller–Hinton agar (MHA) plates. The plates were incubated overnight at 37 °C to obtain sufficient bacterial growth. Subsequently, 200 µL of the bacterial subculture was spread over the MHA surface in three different directions using a sterile cotton swab. Four wells, each 6 mm in diameter and approximately 2.5 cm apart, were then prepared on each inoculated plate using a sterile glass pipette. Different concentrations of the Mn-doped ZnO and 5-FU-loaded Mn-doped ZnO nanocomposites, prepared by diluting the 10 mg/mL stock solution with deionized water, were added to the respective wells. Amoxicillin (1 mg/mL) was used as the positive control, and deionized water as the negative control. The plates were incubated at 37 °C for 24 h, after which the zones of inhibition surrounding the wells were measured to evaluate the antibacterial activity of the tested samples. Antibacterial activity was evaluated against the synthesized nanocomposites at different concentrations using two bacterial strains, E. coli and S. aureus. The synthesized nanocomposites demonstrated significant antibacterial activity against both Gram-negative and Gram-positive bacteria.

Increased antibacterial activity was observed as nanocomposite concentration increased, indicating a concentration-dependent effect. Higher concentrations produced larger zones of inhibition against both bacterial species, suggesting stronger interactions between the nanocomposites and bacterial cells. These findings indicate that the synthesized nanocomposites possess promising antibacterial activity. Among the synthesized nanocomposites and the positive control, amoxicillin, the 5-FU-loaded Mn-doped ZnO nanocomposite exhibited the highest antibacterial activity against both S. aureus and E. coli, as shown in Tables 2 and 3. As presented in Figure 17, different concentrations of the synthesized nanocomposites were evaluated against S. aureus. Among the tested samples, the 5-FU-loaded Mn-doped ZnO nanocomposite showed enhanced antibacterial activity, with inhibition zones of 13.8 and 16.8 mm at concentrations of 10 and 15 μL, respectively.

TABLE 2

Sr NoAntibiotic drug and NCsZone of inhibition at concentration(10 µL) against S. aureusZone of inhibition at concentration(15 µL) against S. aureus
1Amoxicillin10.5 mm12.8 mm
2Mn doped ZnO NCs7.5 mm8.5 mm
35-FU + Mn doped ZnO NCs13.8 mm16.8 mm

Zone of inhibition (mm) showing the concentration-dependent antibacterial activity of Mn-doped ZnO nanocomposite, 5-FU-loaded Mn-doped ZnO nanocomposite, and amoxicillin against S. aureus using the agar well diffusion method.

TABLE 3

Sr NoAntibiotic drug and NCsZone of inhibition at concentration(10 µL) against E. coliZone of inhibition at concentration(15 µL) against E. coli
1Amoxicillin8.6 mm10.8 mm
2Mn doped ZnO NCs5.3 mm6.5 mm
35-FU + Mn doped ZnO NCs12.5 mm14.8 mm

Zone of inhibition (mm) showing the concentration-dependent antibacterial activity of Mn-doped ZnO nanocomposite, 5-FU-loaded Mn-doped ZnO nanocomposite, and amoxicillin against E. coli using the agar well diffusion method.

FIGURE 17

The antibacterial activity of the prepared nanocomposites was evaluated against two bacterial strains at concentrations of 10 and 15 µL. The results demonstrated a concentration-dependent increase in antibacterial activity for the tested nanocomposites and the positive control, amoxicillin. Among the tested samples, the 5-FU-loaded Mn-doped ZnO nanocomposite exhibited the highest antibacterial activity against both S. aureus and E. coli, producing greater inhibition than amoxicillin, the Mn-doped ZnO nanocomposite, and the negative control. Amoxicillin showed moderate antibacterial activity, whereas the Mn-doped ZnO nanocomposite exhibited comparatively lower activity. The negative control showed no significant antibacterial effect, as presented in Figures 17, 18.

FIGURE 18

Among the two synthesized nanocomposites, the 5-FU + Mn doped ZnO nanocomposite showed enhanced antibacterial activity and was more sensitive against S. aureus, as shown in Table 2. 5-FU + Mn doped ZnO NCs showed a higher zone of inhibition, 16.8 mm, against S. aureus at 15 mm and 14.8 mm against E. coli at a concentration of 15 μL. At a concentration of 10 μL, the 5-FU + Mn-doped ZnO nanocomposite showed a higher zone of inhibition, 13.8 mm, against S. aureus and 12.5 mm against E. coli, as shown in Figure 19.

FIGURE 19

Overall, the findings indicate that the 5-FU-loaded Mn-doped ZnO nanocomposite possesses strong concentration-dependent antibacterial activity against both bacterial strains, as shown in Figure 20.

FIGURE 20

Among all the samples, the physical mixture of 5-FU + Mn doped ZnO nanocomposite showed moderate antibacterial activity of 10.4 mm against S. aureus and 9.2 mm against E. coli at a concentration of 15 μL and was more sensitive against S. aureus, as presented in Table 4.

TABLE 4

Sr NoAntibiotic drug and NCsZone of inhibition at concentration(15 µL) against
S. aureus
Zone of inhibition at concentration(15 µL) against
E. coli
1Amoxicillin12.6 mm10.9 mm
2Free 5-FU6.2 mm5.4 mm
3Physical mixture
5-FU + Mn doped ZnO NCs
10.4 mm9.2 mm

Zone of inhibition (mm) antibacterial activity of positive control amoxicillin, free 5-FU, and Physical mixture 5-FU + Mn doped ZnO nanocomposite against E. coli and S. aureus as determined by the agar well diffusion method.

The antibacterial activity of free 5-FU and the physical mixture of 5-FU with Mn-doped ZnO was compared with that of the positive control, amoxicillin, against E. coli and S. aureus at a concentration of 15 μL, as shown in Figure 21. The negative control showed no appreciable inhibition zone, indicating that the solvent or vehicle itself did not contribute substantially to the observed antibacterial activity. Free 5-FU exhibited relatively weak antibacterial activity, producing inhibition zones of 5.4 mm against E. coli and 6.2 mm against S. aureus. The relatively limited activity of free 5-FU suggests that, although 5-FU possesses intrinsic antibacterial properties, its direct antibacterial effect under the present experimental conditions is modest. This may relate to its mechanism of action, which involves interference with thymidylate synthase and nucleic acid metabolism and requires sufficient intracellular exposure to exert a pronounced antibacterial effect.

FIGURE 21

In comparison, the physical mixture of 5-FU and Mn-doped ZnO exhibited a visibly greater inhibitory response than free 5-FU in the agar well diffusion assay, particularly against S. aureus. This enhanced response may reflect the complementary antibacterial properties of the two components. Mn-doped ZnO can interact with bacterial cell surfaces and may contribute to membrane disruption, metal-ion-mediated effects, and oxidative stress, whereas 5-FU can interfere with bacterial nucleic-acid metabolism. The combined presence of these components may therefore increase the overall antibacterial effect compared with free 5-FU alone.

Amoxicillin, used as the positive control, produced the largest inhibition zone among the comparative treatments, demonstrating its established antibacterial efficacy under the experimental conditions. The difference between amoxicillin and the test formulations also provides an appropriate reference for assessing the nanocomposite-based system’s relative antibacterial performance. Overall, Figure 21 demonstrates that free 5-FU has limited antibacterial activity, whereas combining 5-FU with Mn-doped ZnO enhances the antibacterial response, supporting the rationale for developing the 5-FU-loaded Mn-doped ZnO nanocomposite.

Figure 22 quantitatively summarizes the antibacterial activity observed in Figure 21, comparing free 5-FU, the physical mixture of 5-FU with Mn-doped ZnO, and amoxicillin against S. aureus and E. coli. Free 5-FU exhibited the lowest activity, with inhibition zones of approximately 6.1 and 5.4 mm against S. aureus and E. coli, respectively.

FIGURE 22

In contrast, the physical mixture produced substantially larger inhibition zones of approximately 10.4 and 9.2 mm, respectively, indicating that incorporating Mn-doped ZnO enhanced the antibacterial response of 5-FU. Amoxicillin produced the largest inhibition zones, approximately 12.6 mm against S. aureus and 11.0 mm against E. coli. Overall, the results demonstrate that the physical mixture markedly improved the antibacterial activity of free 5-FU against both bacterial strains, although its activity remained lower than that of amoxicillin under the tested conditions. S. aureus also showed slightly greater susceptibility than E. coli to all tested treatments.

3.7 Cytotoxicity assessment

The cytotoxicity of the 5-FU-loaded Mn-doped ZnO nanocomposite was evaluated using the MTT assay in NIH-3T3 and HEK-293 cell lines. Briefly, 5,000 cells/well were seeded into 96-well plates and incubated at 37 °C in a humidified 5% CO2 atmosphere for 24 h to allow adequate cell attachment and stabilization. Following cell attachment, the culture medium was replaced with fresh medium containing the 5-FU-loaded Mn-doped ZnO nanocomposite, and the cells were incubated for 24, 48, and 72 h to evaluate the time-dependent effects of the treatment. During incubation, exposure to the nanocomposite may affect cellular metabolic activity and viability, depending on treatment duration and cellular response.

Cell viability was subsequently assessed using the MTT assay. The MTT reagent, a yellow tetrazolium compound, is reduced by metabolically active living cells to insoluble purple formazan crystals. After treatment, MTT reagent was added to the wells, followed by incubation for 4 h to allow sufficient formazan crystal formation. We then carefully removed the culture medium and added dimethyl sulfoxide (DMSO) to dissolve the formazan crystals. We measured the absorbance (optical density, OD) of each well at 490 nm using a microplate reader. The measured OD values indicated cellular metabolic activity and viability, with higher OD values corresponding to more metabolically active, viable cells. The cytotoxic effect of the 5-FU-loaded Mn-doped ZnO nanocomposite was therefore assessed based on changes in cell viability relative to the appropriate untreated control. We calculated cell viability using the following Equation 5.

OD1 = Treated sample.

OD2 = Untreated control.

OD3 = Blank.

A clear concentration-dependent reduction in the viability of NIH-3T3 and HEK-293 cells was observed following treatment with 5-FU-loaded Mn-doped ZnO nanocomposites, as shown in Figure 23. Cell viability remained relatively high at lower concentrations, but decreased markedly as nanocomposite concentration increased, reaching approximately 40%–43% at 100 μg/mL. Viability decreased modestly as exposure time increased from 24 to 72 h, indicating a comparatively weaker time-dependent effect.

FIGURE 23

The pronounced reduction in viability at higher concentrations may reflect increased cellular stress and damage from exposure to the combined 5-FU/Mn-doped ZnO system. However, because the MTT assay did not directly quantify specific mechanisms such as ROS generation or apoptosis, these mechanisms remain proposed rather than experimentally confirmed. Overall, the results indicate that the cytotoxic response of the 5-FU-loaded Mn-doped ZnO nanocomposite is predominantly concentration-dependent, with relatively high cell viability maintained at lower concentrations.

3.8 ROS-mediated Killing mechanism

ZnO is an effective antimicrobial material, particularly under suitable light irradiation, where photoinduced reactive oxygen species (ROS) can contribute to microbial inactivation. Upon exposure to light, ZnO generates electron–hole pairs that can participate in redox reactions and produce ROS, which can cause oxidative damage to microbial cells. Metal doping has been explored as a strategy to modify the optical and electronic properties of ZnO and potentially enhance its ROS-generating capability (Makauki et al., 2025). Mn-doped ZnO nanocomposites have also demonstrated promising anticancer activity and selectivity toward cancer cells, with effects associated with ROS generation, oxidative stress, apoptosis, DNA damage, and cell-cycle arrest (Selim et al., 2026). Furthermore, Mn doping may modulate ROS production and oxidative stress, potentially reducing oxidative damage to healthy cells. Higher Mn concentrations have been reported to reduce ROS production and DNA fragmentation in healthy cells, suggesting that Mn doping may enhance biocompatibility by modulating oxidative stress (Popescu et al., 2020).

4 Conclusions

5-Fluorouracil (5-FU)-loaded Mn-doped ZnO nanocomposites were successfully synthesized using a simple, economical, and scalable co-precipitation method. Structural, chemical, morphological, and elemental analyses using XRD, FTIR, UV–Vis spectroscopy, SEM, and EDX collectively supported the successful formation of the Mn-doped ZnO nanocomposite and incorporation of 5-FU. The nanocomposite exhibited sustained 5-FU release, reaching approximately 71% cumulative release after 120 h, indicating its potential as a controlled drug-delivery platform. Importantly, the 5-FU-loaded Mn-doped ZnO nanocomposite demonstrated concentration-dependent antibacterial activity against both E. coli and S. aureus, with greater activity than the unloaded Mn-doped ZnO nanocomposite and the positive control, amoxicillin, under the tested conditions. The highest antibacterial activity was observed against S. aureus, with inhibition zones of 13.8 and 16.8 mm at 10 and 15 μL, respectively. Overall, the findings demonstrate that combining 5-FU with Mn-doped ZnO can provide a multifunctional nanocomposite with sustained drug-release characteristics and enhanced antibacterial activity, highlighting its potential for further investigation as a nanostructured antimicrobial delivery system.

Statements

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.

Author contributions

RZ: Conceptualization, Methodology, Writing – original draft. IJ: Data curation, Writing – review and editing. SB: Formal Analysis, Writing – original draft. FN: Conceptualization, Supervision, Writing – review and editing. SH: Resources, Validation, Writing – review and editing. MH: Project administration, Visualization, Writing – review and editing.

Funding

The author(s) declared that financial support was not received for this work and/or its publication.

Acknowledgments

The authors would like to thank their respective institutions for the general support for this work.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that generative AI was used in the creation of this manuscript. The authors acknowledge the use of the regenerative AI tools (ChatGPT and Grammarly) to enhance linguistic consistency and clarity throughout the manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmats.2026.1911252/full#supplementary-material

References

  • 1

    AbedA.KarimiM.NejatiM.HamblinM. R.MirzaeiS. A.SarvizadehM.et al (2025). Synthesis of 5-Fluorouracil (5-FU) coated platinum nanoparticles and apoptotic effects on U87 human glioblastoma cells. Cancer Cell Int.25, 280. 10.1186/s12935-025-03893-w

  • 2

    AlzahraniS. M.Al DoghaitherH. A.Al-GhafariA. B.PushparajP. N. (2023). 5-Fluorouracil and capecitabine therapies for the treatment of colorectal cancer. Oncol. Rep.50, 175. 10.3892/or.2023.8612

  • 3

    AnjumS.NaseerF.AhmadT.JahanF.QadirH.GulR.et al (2024). Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer. Sci. Rep.14, 11431. 10.1038/s41598-024-55900-1

  • 4

    ArafatM.FouladianP.WignallA.SongY.ParikhA.AlbrechtH.et al (2020). Development and in vitro evaluation of 5-fluorouracil-eluting stents for the treatment of colorectal cancer and cancer-related obstruction. Pharmaceutics13, 17. 10.3390/pharmaceutics13010017

  • 5

    BibiS.NawazF.JamilI.BibiN.KhanJ.HassanS. W. (2025). Synthesis, characterization, and antimicrobial activity of Ca‐Sn Co‐Doped ZnO nanoparticles via a co‐precipitation route. ChemistrySelect10, e01523. 10.1002/slct.202501523

  • 6

    BonifácioM. A. R.LiraH. d. L.NeivaL. S.KiminamiR. H.GamaL. (2017). Nanoparticles of ZnO doped with Mn: structural and morphological characteristics. Mater. Res.20, 1044–1049. 10.1590/1980-5373-mr-2015-0765

  • 7

    ChandrakalaV.ArunaV.AngajalaG. (2022). Review on metal nanoparticles as nanocarriers: current challenges and perspectives in drug delivery systems. Emergent Mater.5, 1593–1615. 10.1007/s42247-021-00335-x

  • 8

    GautamS.DasD. K.KaurJ.KumarA.UbaidullahM.HasanM.et al (2023). Transition metal-based nanoparticles as potential antimicrobial agents: recent advancements, mechanistic, challenges, and future prospects. Discov. Nano18, 84. 10.1186/s11671-023-03861-1

  • 9

    HaleemA.JavaidM.SinghR. P.RabS.SumanR. (2023). Applications of nanotechnology in medical field: a brief review. Glob. Health J.7, 70–77. 10.1016/j.glohj.2023.02.008

  • 10

    HaqueB.GuptaA.RoyA.MalikA.KhanA. A. (2025). Green fabrication of Ag–Ni–Mn-Zn nanoparticles from watermelon peels and its antioxidant, dye degradation and molecular docking studies. Clean Technol. Environ. Policy27, 993–1020. 10.1007/s10098-024-02906-y

  • 11

    IbraheemD. R.HusseinN. N.SulaimanG. M.MohammedH. A.KhanR. A.Al RugaieO. (2022). Ciprofloxacin-loaded silver nanoparticles as potent nano-antibiotics against resistant pathogenic bacteria. Nanomaterials12, 2808. 10.3390/nano12162808

  • 12

    IngleP. U.BiswasJ. K.MondalM.RaiM. K.KumarP. S.GadeA. K. (2022). Assessment of in vitro antimicrobial efficacy of biologically synthesized metal nanoparticles against pathogenic bacteria. Chemosphere291, 132676. 10.1016/j.chemosphere.2021.132676

  • 13

    JamilI.NawazF.ShafiqM.RashidM.AkramA.SiddiqueA.et al (2024a). A recent trends on green synthesis and bioactivity of imidazole. Univers. J. Green Chem.2 (1), 50–88. 10.37256/ujgc.2120244234

  • 14

    JamilI.AhmadF.KhanM. I.ShanablehA.FarooqN.AnjumS.et al (2024b). A review of the gold nanoparticles' synthesis and application in dye degradation. Clean. Chem. Eng.10, 100126. 10.1016/j.clce.2024.100126

  • 15

    JamilI.AlasiriA.NawazF.RashidM.ElfarA. A.HoqueM. E. (2026). Synthesis, Characterization, and Kinetic Insights of MnZnFe2O4/SrWO4 Ferrite–Tungstate Nanocomposite for Rapid Photocatalytic Degradation of Imidacloprid.

  • 16

    JosephT. M.Kar MahapatraD.EsmaeiliA.PiszczykŁ.HasaninM. S.KattaliM.et al (2023). Nanoparticles: taking a unique position in medicine. Nanomaterials13, 574. 10.3390/nano13030574

  • 17

    JubeenF.LiaqatA.AmjadF.SultanM.IqbalS. Z.SajidI.et al (2020). Synthesis of 5-fluorouracil cocrystals with novel organic acids as coformers and anticancer evaluation against HCT-116 colorectal cell lines. Cryst. Growth and Des.20, 2406–2414. 10.1021/acs.cgd.9b01570

  • 18

    JunaidA.NoreenF.KhanF.AlharthyR. D.ShahS. I. A.ShahsawarA.et al (2026). Folate-conjugated chitosan/Zn-MOF for targeted 5-fluorouracil delivery in hepatocellular carcinoma. Int. J. Biol. Macromol., 150693. 10.1016/j.ijbiomac.2026.150693jam

  • 19

    KiouriD. P.TsoupraE.PeanaM.PerlepesS. P.StefanidouM. E.ChasapisC. T. (2023). Multifunctional role of zinc in human health: an update. EXCLI Journal22, 809. 10.17179/excli2023-6335

  • 20

    LiY.ZhuJ.ZhaoN.MaG.LiuB.XuJ. (2023). RETRACTED ARTICLE: ZnO as a promising nanocarrier for efficient delivery of 5-fluorouracil anticancer drug. J. Iran. Chem. Soc.20, 2871–2877. 10.1007/s13738-023-02883-x

  • 21

    LinE.-S.HuangC.-Y. (2024). Binding pattern and structural interactome of the anticancer drug 5-Fluorouracil: a critical review. Int. J. Mol. Sci.25, 3404. 10.3390/ijms25063404

  • 22

    MafiA.RezaeeM.HedayatiN.HoganS. D.ReiterR. J.AarabiM.-H.et al (2023). Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy. Cell Commun. Signal.21, 33. 10.1186/s12964-023-01047-x

  • 23

    MakaukiE.MachundaR.BasuO.RwizaM. (2025). Synergistic antimicrobial mechanisms of silver-doped zinc oxide for water treatment: a systematic review. H2Open J.8, 72–88. 10.2166/h2oj.2025.037

  • 24

    MalikS.MuhammadK.WaheedY. (2023). Emerging applications of nanotechnology in healthcare and medicine. Molecules28, 6624. 10.3390/molecules28186624

  • 25

    ManavalanR. K.EnochK.VolegovA. S.AngusamyG.NallasivamS. (2024). Review on medical applications of manganese oxide (Mn2+, Mn3+, and Mn4+) magnetic nanoparticles. J. Nanomater.2024, 1073915–1073929. 10.1155/2024/1073915

  • 26

    MohammadF.BwatanglangI. B.Al-LohedanH. A.ShaikJ. P.MoosaviM.DahanW. M.et al (2023). Magnetically controlled drug delivery and hyperthermia effects of core-shell Cu@ Mn3O4 nanoparticles towards cancer cells in vitro. Int. J. Biol. Macromol.249, 126071. 10.1016/j.ijbiomac.2023.126071

  • 27

    MuteebG.RehmanM. T.ShahwanM.AatifM. (2023). Origin of antibiotics and antibiotic watertance, and their impacts on drug development: a narrative review. Pharmaceuticals16, 1615. 10.3390/ph16111615

  • 28

    NawazF.JamilI.ShakoorB. (2023). “Green synthesis of copper, silver, and gold nanoparticles: applications in medicinal chemistry,” in Green Chemistry for Environmental sustainability-prevention-assurance-sustainability (PAS) Approach (IntechOpen).

  • 29

    PallyV.NegiA.VelamakanniR. P.MeruguR. (2024). Upcycling E-Waste: mn/zno-ncs for antibacterial and anticancer applications. Chem. Afr.7, 5329–5337. 10.1007/s42250-024-01114-x

  • 30

    PinoP.BoscoF.MolleaC.OnidaB. (2023). Antimicrobial nano-zinc oxide biocomposites for wound healing applications: a review. Pharmaceutics15, 970. 10.3390/pharmaceutics15030970

  • 31

    PopescuT.MateiC. O.VlaicuI. D.TivigI.KuncserA. C.StefanM.et al (2020). Influence of surfactant-tailored Mn-doped ZnO nanoparticles on ROS production and DNA damage induced in murine fibroblast cells. Sci. Reports10, 18062. 10.1038/s41598-020-74816-0

  • 32

    PSV.VTK. (2024). Photocatalytic and antimicrobial activities of pure and Mn doped ZnO nanoparticles synthesised by Annona muricata leaf extract. Int. J. Environ. Anal. Chem.104, 5083–5098. 10.1080/03067319.2022.2118581

  • 33

    SavcıA.TuranN.BuldurunK.AlkışM. E.AlanY. (2022). Schiff base containing fluorouracil and its M (II) complexes: synthesis, characterization, cytotoxic and antioxidant activities. Inorg. Chem. Commun.143, 109780. 10.1016/j.inoche.2022.109780

  • 34

    SayedM. A.El-ZeinyH. M.KhimJ. S.AjaremJ. S.AllamA. A.AbukhadraM. R. (2022). Insight into the loading properties of Na+ green-functionalized clinoptilolite as a potential carrier for the 5-Fluorouracil drug, its release kinetics, and viatoxicity. ACS Omega7, 6991–7001. 10.1021/acsomega.1c06671

  • 35

    SelimS.AlhujailyA.SaiedE.HashemA. H.ElkadyF. M.AbdelazizA. M.et al (2026). Fungal-mediated green synthesis of ZnO–MnO nanocomposites with antimicrobial and anticancer properties. Sci. Rep., 10842. 10.1038/s41598-026-45546-6

  • 36

    SinghA.RajputV. D.PandeyD.SharmaR.GhazaryanK.MinkinaT. (2023). Nano zinc-enabled strategies in crops for combatting zinc malnutrition in human health. Front. Bioscience-Landmark28, 158. 10.31083/j.fbl2808158

  • 37

    SuetsuguT.MoriR.FutamuraM.FukadaM.TanakaH.YasufukuI.et al (2021). Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines. Oncol. Rep.45, 1–8. 10.3892/or.2021.7978

  • 38

    SzentirmaiÉ.MassieA. R.KapásL. (2021). Lipoteichoic acid, a cell wall component of Gram-positive bacteria, induces sleep and fever and suppresses feeding. Brain, Behavior, Immunity92, 184–192. 10.1016/j.bbi.2020.12.008

  • 39

    VermaT.AggarwalA.SinghS.SharmaS.SarmaS. J. (2022). Current challenges and advancements towards discovery and resistance of antibiotics. J. Mol. Struct.1248, 131380. 10.1016/j.molstruc.2021.131380

  • 40

    XiaY.GuM.WangJ.ZhangX.ShenT.ShiX.et al (2024). Tumor microenvironment-activated, immunomodulatory nanosheets loaded with copper (II) and 5-FU for synergistic chemodynamic therapy and chemotherapy. J. Colloid Interface Sci.653, 137–147. 10.1016/j.jcis.2023.09.042

  • 41

    YueM.FengZ.GaoL.FuY.YeF. (2026). Synthesis and characterization of spherical C/ZnO/polydopamine composites as carriers for 5-fluorouracil: a focus on sustained release performance. Appl. Surf. Sci.729, 166225. 10.1016/j.apsusc.2026.166225

  • 42

    ZhangM.SongH.YangS.ZhangY.TianY.WangY.et al (2024). Deciphering the antibacterial mechanisms of 5-fluorouracil in Escherichia coli through biochemical and transcriptomic analyses. Antibiotics13, 528. 10.3390/antibiotics13060528

  • 43

    ZhangR.LinH.WangZ.ChengS.LiC.WangY. (2025). Research progress on antimicrobial biomaterials. Macromol. Biosci.25, e00239. 10.1002/mabi.202500239

  • 44

    ZhaoY.LanY.ChangQ.ZhouF.LinY.LiawP. K.et al (2026). Research progress on metal‐organic framework materials in corrosion‐resistant and antimicrobial metal functional coatings. Rare Met.45, e70377. 10.1002/rar2.70377

  • 45

    ZhouX.-Q.HayatZ.ZhangD.-D.LiM.-Y.HuS.WuQ.et al (2023). Zinc oxide nanoparticles: synthesis, characterization, modification, and applications in food and agriculture. Processes11, 1193. 10.3390/pr11041193

  • 46

    ZhuX.LiJ.YangS.ZhangW.LiX.TangH.et al (2025). Molecular dynamics simulation on orientation-dependent mechanical behaviors of ZnO single crystals under nanoindentation. Materials18, 3905. 10.3390/ma18163905

Summary

Keywords

5-fluorouracil, antimicrobial therapy, co-precipitation, Mn-doped, nanocomposites

Citation

Zafar R, Jamil I, Bibi S, Nawaz F, Hassan SW and Hoque ME (2026) 5-fluorouracil-loaded Mn-doped ZnO nanocomposite: synthesis, characterization, and antibacterial activity. Front. Mater. 13:1911252. doi: 10.3389/fmats.2026.1911252

Received

16 June 2026

Revised

14 August 2026

Accepted

04 September 2026

Published

30 October 2026

Volume

13 - 2026

Edited by

Daniela Šojić Merkulov, University of Novi Sad, Serbia

Reviewed by

Ehsan Nazarzadeh Zare, Damghan University, Iran

Afsaneh Arshadi Edlo, University of Tehran, Iran

Updates

Copyright

*Correspondence: Md Enamul Hoque, ; Faisal Nawaz,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics